Silverarc Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-146,657
| Closed | -$6.6M | – | 72 |
|
|
2024
Q3 | $6.6M | Buy |
+146,657
| New | +$6.6M | 1.48% | 21 |
|
|
2023
Q3 | – | Sell |
-25,000
| Closed | -$691K | – | 85 |
|
|
2023
Q2 | $691K | Sell |
25,000
-80,486
| -76% | -$2.22M | 0.21% | 61 |
|
|
2023
Q1 | $2.43M | Buy |
+105,486
| New | +$2.43M | 1% | 35 |
|
|
2021
Q1 | – | Sell |
-20,910
| Closed | -$422K | – | 96 |
|
|
2020
Q4 | $422K | Buy |
+20,910
| New | +$422K | 0.25% | 73 |
|